• OPEN AN ACCOUNT
Indian Indices
Sensex
82,584.69 552.88
( 0.67%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,472.71 448.43
(0.76%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.54 -0.42
(-0.44%)
EUR-INR
102.90 -0.55
(-0.53%)
GBP-INR
123.45 -0.54
(-0.44%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
44.9147092
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
5.76
17.79
EPS(TTM)
Face Value()
Div & Yield %
7.2
10
0
 

IIFL Finance jumps after block deal
Nov 18,2026
Trading volumes were significantly higher than average. On the BSE, around 6.77 crore shares changed hands against the three-month average of 1.64 lakh shares. On the NSE, 1.85 crore shares were traded compared with the three-month average of 30.75 lakh shares.

The block deal follows reports that Canada's Fairfax Group is selling its entire 13.3% stake in IIFL Finance through a transaction valued at approximately Rs 3,450 crore.

FIH Mauritius Investments, a Fairfax Group entity, has mandated IIFL Capital, a group company, to sell more than 5.6 crore shares of IIFL Finance on Wednesday, 18 November 2026.

According to reports, the shares are being offered at a floor price of Rs 611 apiece, representing a 3.9% discount to IIFL Finance's closing price of Rs 636 on the BSE on Tuesday.

Despite its exit from IIFL Finance, Fairfax continues to hold a 38.05% stake in IIFL Capital, according to shareholding data.

IIFL Finance is a retail-focused NBFC offering diversified loan products, including gold finance, business, home, microfinance, and other secured lending solutions. It ha a network of 5,091 branches and a presence across urban and rural India.

On a consolidated basis, IIFL Finance's total income increased 23% year on year to Rs 2,339.6 crore, while pre-provision operating profit (PPoP) rose 31% to Rs 1,355.1 crore. Profit before tax surged 93% to Rs 1,073.7 crore, supported by operating leverage and lower loan losses and provisions.

Profit after tax (PAT), before non-controlling interest (NCI), stood at Rs 805 crore in Q2 FY27, up 93% year on year, reflecting the continued strength of the company's secured lending strategy.